Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 13049 perindopril-erbumin; 12990 amlodipin-besilÁt - tableta - 8mg/10mg - perindopril a amlodipin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 13049 perindopril-erbumin; 12990 amlodipin-besilÁt - tableta - 8mg/5mg - perindopril a amlodipin

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - léky užívané při diabetu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Evropská unie - čeština - EMA (European Medicines Agency)

sanofi winthrop industrie - lixisenatid - diabetes mellitus, typ 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - léky užívané při diabetu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

gedeon richter plc., budapešť array - 12970 dihydrÁt lisinoprilu; 12990 amlodipin-besilÁt - tableta - 10mg/5mg - lisinopril a amlodipin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

gedeon richter plc., budapešť array - 12970 dihydrÁt lisinoprilu; 12990 amlodipin-besilÁt - tableta - 20mg/10mg - lisinopril a amlodipin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

gedeon richter plc., budapešť array - 12970 dihydrÁt lisinoprilu; 12990 amlodipin-besilÁt - tableta - 20mg/5mg - lisinopril a amlodipin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 13049 perindopril-erbumin; 12990 amlodipin-besilÁt - tableta - 4mg/10mg - perindopril a amlodipin